Gyre Therapeutics is trading 5.21% up at $6.87 on October 28, 2026, with no clear company-specific announcement identified to explain the intraday gain. - The latest identified company release predates this move. - XBI is up 2.18% in the supplied market context; this may be supportive but does not establish the cause of the stock’s move. - Broader major indexes were mixed, making a market-wide explanation less clear.